Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
(Metyrapone + oxazepam) by Embera NeuroTherapeutics for Substance (Drug) Abuse: Likelihood of Approval
(Metyrapone + oxazepam) is under clinical development by Embera NeuroTherapeutics and currently in Phase II for Substance (Drug) Abuse. According...